Advancing Risk Analysis for Nanoscale Materials: Report from an International Workshop on the Role of Alternative Testing Strategies for Advancement

J. A. Shatkin, Kimberly J. Ong, Christian Beaudrie, Amy J. Clippinger, Christine Ogilvie Hendren, Lynne T. Haber, Myriam Hill, Patricia Holden, Alan J. Kennedy, Baram Kim, Margaret MacDonell, Christina M. Powers, Monita Sharma, Lorraine Sheremeta, Vicki Stone, Yasir Sultan, Audrey Turley, Ronald H. White

Research output: Contribution to journalArticle

Abstract

The Society for Risk Analysis (SRA) has a history of bringing thought leadership to topics of emerging risk. In September 2014, the SRA Emerging Nanoscale Materials Specialty Group convened an international workshop to examine the use of alternative testing strategies (ATS) for manufactured nanomaterials (NM) from a risk analysis perspective. Experts in NM environmental health and safety, human health, ecotoxicology, regulatory compliance, risk analysis, and ATS evaluated and discussed the state of the science for in vitro and other alternatives to traditional toxicology testing for NM. Based on this review, experts recommended immediate and near-term actions that would advance ATS use in NM risk assessment. Three focal areas—human health, ecological health, and exposure considerations—shaped deliberations about information needs, priorities, and the next steps required to increase confidence in and use of ATS in NM risk assessment. The deliberations revealed that ATS are now being used for screening, and that, in the near term, ATS could be developed for use in read-across or categorization decision making within certain regulatory frameworks. Participants recognized that leadership is required from within the scientific community to address basic challenges, including standardizing materials, protocols, techniques and reporting, and designing experiments relevant to real-world conditions, as well as coordination and sharing of large-scale collaborations and data. Experts agreed that it will be critical to include experimental parameters that can support the development of adverse outcome pathways. Numerous other insightful ideas for investment in ATS emerged throughout the discussions and are further highlighted in this article.

Original languageEnglish (US)
Pages (from-to)1520-1537
Number of pages18
JournalRisk Analysis
Volume36
Issue number8
DOIs
StatePublished - Aug 1 2016
Externally publishedYes

Fingerprint

Nanostructures
Risk analysis
Education
Nanostructured materials
Testing
Health
Ecotoxicology
Risk assessment
Environmental Health
Toxicology
Compliance
Decision Making
Safety
Screening
Decision making
History

Keywords

  • Alternative testing strategies
  • expert workshop
  • nanomaterials
  • nanotoxicology
  • risk analysis

ASJC Scopus subject areas

  • Safety, Risk, Reliability and Quality
  • Physiology (medical)

Cite this

Advancing Risk Analysis for Nanoscale Materials : Report from an International Workshop on the Role of Alternative Testing Strategies for Advancement. / Shatkin, J. A.; Ong, Kimberly J.; Beaudrie, Christian; Clippinger, Amy J.; Hendren, Christine Ogilvie; Haber, Lynne T.; Hill, Myriam; Holden, Patricia; Kennedy, Alan J.; Kim, Baram; MacDonell, Margaret; Powers, Christina M.; Sharma, Monita; Sheremeta, Lorraine; Stone, Vicki; Sultan, Yasir; Turley, Audrey; White, Ronald H.

In: Risk Analysis, Vol. 36, No. 8, 01.08.2016, p. 1520-1537.

Research output: Contribution to journalArticle

Shatkin, JA, Ong, KJ, Beaudrie, C, Clippinger, AJ, Hendren, CO, Haber, LT, Hill, M, Holden, P, Kennedy, AJ, Kim, B, MacDonell, M, Powers, CM, Sharma, M, Sheremeta, L, Stone, V, Sultan, Y, Turley, A & White, RH 2016, 'Advancing Risk Analysis for Nanoscale Materials: Report from an International Workshop on the Role of Alternative Testing Strategies for Advancement', Risk Analysis, vol. 36, no. 8, pp. 1520-1537. https://doi.org/10.1111/risa.12683
Shatkin, J. A. ; Ong, Kimberly J. ; Beaudrie, Christian ; Clippinger, Amy J. ; Hendren, Christine Ogilvie ; Haber, Lynne T. ; Hill, Myriam ; Holden, Patricia ; Kennedy, Alan J. ; Kim, Baram ; MacDonell, Margaret ; Powers, Christina M. ; Sharma, Monita ; Sheremeta, Lorraine ; Stone, Vicki ; Sultan, Yasir ; Turley, Audrey ; White, Ronald H. / Advancing Risk Analysis for Nanoscale Materials : Report from an International Workshop on the Role of Alternative Testing Strategies for Advancement. In: Risk Analysis. 2016 ; Vol. 36, No. 8. pp. 1520-1537.
@article{25b662d067b54923baddc1822434511a,
title = "Advancing Risk Analysis for Nanoscale Materials: Report from an International Workshop on the Role of Alternative Testing Strategies for Advancement",
abstract = "The Society for Risk Analysis (SRA) has a history of bringing thought leadership to topics of emerging risk. In September 2014, the SRA Emerging Nanoscale Materials Specialty Group convened an international workshop to examine the use of alternative testing strategies (ATS) for manufactured nanomaterials (NM) from a risk analysis perspective. Experts in NM environmental health and safety, human health, ecotoxicology, regulatory compliance, risk analysis, and ATS evaluated and discussed the state of the science for in vitro and other alternatives to traditional toxicology testing for NM. Based on this review, experts recommended immediate and near-term actions that would advance ATS use in NM risk assessment. Three focal areas—human health, ecological health, and exposure considerations—shaped deliberations about information needs, priorities, and the next steps required to increase confidence in and use of ATS in NM risk assessment. The deliberations revealed that ATS are now being used for screening, and that, in the near term, ATS could be developed for use in read-across or categorization decision making within certain regulatory frameworks. Participants recognized that leadership is required from within the scientific community to address basic challenges, including standardizing materials, protocols, techniques and reporting, and designing experiments relevant to real-world conditions, as well as coordination and sharing of large-scale collaborations and data. Experts agreed that it will be critical to include experimental parameters that can support the development of adverse outcome pathways. Numerous other insightful ideas for investment in ATS emerged throughout the discussions and are further highlighted in this article.",
keywords = "Alternative testing strategies, expert workshop, nanomaterials, nanotoxicology, risk analysis",
author = "Shatkin, {J. A.} and Ong, {Kimberly J.} and Christian Beaudrie and Clippinger, {Amy J.} and Hendren, {Christine Ogilvie} and Haber, {Lynne T.} and Myriam Hill and Patricia Holden and Kennedy, {Alan J.} and Baram Kim and Margaret MacDonell and Powers, {Christina M.} and Monita Sharma and Lorraine Sheremeta and Vicki Stone and Yasir Sultan and Audrey Turley and White, {Ronald H.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1111/risa.12683",
language = "English (US)",
volume = "36",
pages = "1520--1537",
journal = "Risk Analysis",
issn = "0272-4332",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Advancing Risk Analysis for Nanoscale Materials

T2 - Report from an International Workshop on the Role of Alternative Testing Strategies for Advancement

AU - Shatkin, J. A.

AU - Ong, Kimberly J.

AU - Beaudrie, Christian

AU - Clippinger, Amy J.

AU - Hendren, Christine Ogilvie

AU - Haber, Lynne T.

AU - Hill, Myriam

AU - Holden, Patricia

AU - Kennedy, Alan J.

AU - Kim, Baram

AU - MacDonell, Margaret

AU - Powers, Christina M.

AU - Sharma, Monita

AU - Sheremeta, Lorraine

AU - Stone, Vicki

AU - Sultan, Yasir

AU - Turley, Audrey

AU - White, Ronald H.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - The Society for Risk Analysis (SRA) has a history of bringing thought leadership to topics of emerging risk. In September 2014, the SRA Emerging Nanoscale Materials Specialty Group convened an international workshop to examine the use of alternative testing strategies (ATS) for manufactured nanomaterials (NM) from a risk analysis perspective. Experts in NM environmental health and safety, human health, ecotoxicology, regulatory compliance, risk analysis, and ATS evaluated and discussed the state of the science for in vitro and other alternatives to traditional toxicology testing for NM. Based on this review, experts recommended immediate and near-term actions that would advance ATS use in NM risk assessment. Three focal areas—human health, ecological health, and exposure considerations—shaped deliberations about information needs, priorities, and the next steps required to increase confidence in and use of ATS in NM risk assessment. The deliberations revealed that ATS are now being used for screening, and that, in the near term, ATS could be developed for use in read-across or categorization decision making within certain regulatory frameworks. Participants recognized that leadership is required from within the scientific community to address basic challenges, including standardizing materials, protocols, techniques and reporting, and designing experiments relevant to real-world conditions, as well as coordination and sharing of large-scale collaborations and data. Experts agreed that it will be critical to include experimental parameters that can support the development of adverse outcome pathways. Numerous other insightful ideas for investment in ATS emerged throughout the discussions and are further highlighted in this article.

AB - The Society for Risk Analysis (SRA) has a history of bringing thought leadership to topics of emerging risk. In September 2014, the SRA Emerging Nanoscale Materials Specialty Group convened an international workshop to examine the use of alternative testing strategies (ATS) for manufactured nanomaterials (NM) from a risk analysis perspective. Experts in NM environmental health and safety, human health, ecotoxicology, regulatory compliance, risk analysis, and ATS evaluated and discussed the state of the science for in vitro and other alternatives to traditional toxicology testing for NM. Based on this review, experts recommended immediate and near-term actions that would advance ATS use in NM risk assessment. Three focal areas—human health, ecological health, and exposure considerations—shaped deliberations about information needs, priorities, and the next steps required to increase confidence in and use of ATS in NM risk assessment. The deliberations revealed that ATS are now being used for screening, and that, in the near term, ATS could be developed for use in read-across or categorization decision making within certain regulatory frameworks. Participants recognized that leadership is required from within the scientific community to address basic challenges, including standardizing materials, protocols, techniques and reporting, and designing experiments relevant to real-world conditions, as well as coordination and sharing of large-scale collaborations and data. Experts agreed that it will be critical to include experimental parameters that can support the development of adverse outcome pathways. Numerous other insightful ideas for investment in ATS emerged throughout the discussions and are further highlighted in this article.

KW - Alternative testing strategies

KW - expert workshop

KW - nanomaterials

KW - nanotoxicology

KW - risk analysis

UR - http://www.scopus.com/inward/record.url?scp=85027921712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027921712&partnerID=8YFLogxK

U2 - 10.1111/risa.12683

DO - 10.1111/risa.12683

M3 - Article

C2 - 27510619

AN - SCOPUS:85027921712

VL - 36

SP - 1520

EP - 1537

JO - Risk Analysis

JF - Risk Analysis

SN - 0272-4332

IS - 8

ER -